Harbin Huarui Biochemical Pharmaceutical

Harbin Huarui Biochemical Pharmaceutical is a specialized pharmaceutical manufacturer based in Harbin, China, and operates as a key subsidiary of the Harbin Pharmaceutical Group (Hayao). The company is recognized for its expertise in biochemical drug development and the production of complex injection formulations, including lipid microspheres and lyophilized powders. Its commercial portfolio is led by Alprostadil, a treatment for cardiovascular and peripheral vascular conditions, alongside a range of antibiotics and nutritional biochemicals. Operating from a large-scale, GMP-certified facility in the Limin Development Zone, the company integrates research, production, and sales to serve both domestic and international markets. Harbin Huarui remains a critical component of its parent group's strategy in the high-value injectable and biochemical segments.